TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22412028

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) administration
Number of subjects: 22699
Study: 20150524

Group type: EXPERIMENTAL
Intervention: CIC 160 µg BID (ex actuator)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CIC 320 µg BID (ex actuator)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: FP 220 µg BID (ex actuator)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: FP 440 µg BID (ex actuator)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 18779511

Group type: EXPERIMENTAL
Intervention: High-rate repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Lateromedial rTMS
Number of subjects: 28
Study: 16501030

Group type: EXPERIMENTAL
Intervention: Vagal-related HRV indexes
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: HRR indexes
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: FitLT and FitMT
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Moderate training
Number of subjects: 55
Study: 14696789

Group type: EXPERIMENTAL
Intervention: Furoxime (250 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Zinnat (250 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Furoxime
Number of subjects: 12
Study: 10792119

Group type: EXPERIMENTAL
Intervention: Levosulpiride (25 mg t.d.s.)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cisapride (10 mg t.d.s.)
Number of subjects: 30
Study: 8554003

Group type: EXPERIMENTAL
Intervention: NYHA class II
Number of subjects: 20

Group type: COMPARATOR
Intervention: NYHA class III
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low-frequency component of the spectrum
Number of subjects: 20
Study: 1886589

Group type: EXPERIMENTAL
Intervention: ADH and epinephrine (Group E)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ADH and dopamine (Group D)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ADH and catecholamine (both groups)
Number of subjects: 20
Study: 7102580

Group type: EXPERIMENTAL
Intervention: 10 mg fluoride supplement in divided doses with meals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with basal diets containing 0.4 mg fluoride per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 mg fluoride supplement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with basal diets
Number of subjects: 0
Study: 30379087

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 29096678

Group type: EXPERIMENTAL
Intervention: Intravenously administered alteplase
Number of subjects: 0
Study: 26416029

Group type: EXPERIMENTAL
Intervention: Learning Collaborative (LC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cascading Model (CM)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Distance Education (DE)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy (EBT)
Number of subjects: 50
Study: 23415985

Group type: EXPERIMENTAL
Intervention: Medication combined with chewing gum
Number of subjects: 30

Group type: COMPARATOR
Intervention: Medication only
Number of subjects: 30
Study: 21537935

Group type: EXPERIMENTAL
Intervention: Music therapy in addition to routine nursing care
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 120
Study: 19303969

Group type: COMPARATOR
Intervention: Standard insulin treatment (3 to 4 injections of insulin daily)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Standard insulin treatment plus an additional day per week of 3 intravenous pulses over an 8‐hour period
Number of subjects: 19
Study: 17347180

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 80
Study: 15264735

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Endotracheal tube
Number of subjects: 60
Study: 11555849

Group type: EXPERIMENTAL
Intervention: Plasma IGF‐I measurement
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Serum IGFBP‐3 measurement
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Serum leptin measurement (women)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Serum leptin measurement (men)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Serum IGFBP‐3 and serum leptin compared to plasma IGF‐I
Number of subjects: 35
Study: 9670267

Group type: EXPERIMENTAL
Intervention: Isolated hyperthermic arterial liver perfusion
Number of subjects: 12
Study: 7923312

Group type: EXPERIMENTAL
Intervention: Ibuprofen lysine 200 mg (IBL 200)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid 500 mg (ASA 500)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study: 2971512

Group type: EXPERIMENTAL
Intervention: 1 percent clindamycin phosphate gel
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: 1 percent clindamycin phosphate solution
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo (gel vehicle)
Number of subjects: 135
Study: 31391223

Group type: EXPERIMENTAL
Intervention: ralinepag
Number of subjects: 61

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 61
Study: 27708251

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Number of subjects: 16
Study: 25438838

Group type: EXPERIMENTAL
Intervention: MRgHIFU (transcranial magnetic resonance imaging-guided high-intensity focused ultrasound)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MRgHIFU
Number of subjects: 0
Study: 23294132

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Analgesia (PCA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous Infusion
Number of subjects: 60
Study: 21536983

Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Metoprolol succinate (50 to 100 mg daily)
Number of subjects: 80
Study: 19561368

Group type: EXPERIMENTAL
Intervention: Virtual-reality-based exercise bike therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard rehabilitation therapy without virtual-reality equipment
Number of subjects: 30
Study: 16432820

Group type: EXPERIMENTAL
Intervention: Transilluminated powered phlebectomy (TIPP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Multiple stab incision phlebectomy (MSIP)
Number of subjects: 62
Study: 15471147

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional treatment
Number of subjects: 0
Study: 11590875

Group type: EXPERIMENTAL
Intervention: 5.2 g n‐3 PUFA daily for 12 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 9125088

Group type: EXPERIMENTAL
Intervention: Chemical/Biological Combat Suit (CBCS)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal combat uniform (DPCU)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Combat uniform (CS)
Number of subjects: 9
Study: 7932174

Group type: EXPERIMENTAL
Intervention: 3-desacetylvecuronium
Number of subjects: 12

Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 12
Study: 2979237

Group type: EXPERIMENTAL
Intervention: Oral micronized testosterone (200 mg t.d.s.)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 29878856

Group type: EXPERIMENTAL
Intervention: 7% Hypertonic Saline (HS)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.1% Hyaluronic Acid + 7% Hypertonic Saline (HA+HS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: 0.9% Isotonic Saline (IS)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Airway Clearance Technique (ACT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Leicester Cough Questionnaire (LCQ) and lung function measurements
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Adverse Events (AEs) monitoring
Number of subjects: 28
Study: 27049056

Group type: EXPERIMENTAL
Intervention: Test spironolactone tablet formulation (100 mg) under fasting condition
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Test spironolactone tablet formulation (100 mg) under fed condition
Number of subjects: 40

Group type: COMPARATOR
Intervention: Reference spironolactone tablet formulation (100 mg) under fasting condition
Number of subjects: 40

Group type: COMPARATOR
Intervention: Reference spironolactone tablet formulation (100 mg) under fed condition
Number of subjects: 40
Study: 25653225

Group type: EXPERIMENTAL
Intervention: Peroneal nerve functional electrical stimulation (FES)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Ankle foot orthosis (AFO)
Number of subjects: 495
Study: 23857878

Group type: EXPERIMENTAL
Intervention: Various drugs (90 drugs assessed)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Amiodarone (antiarrhythmic)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Terfenadine (antihistaminic)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Quinidine (antiarrhythmic)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Trimipramine (tricyclic antidepressant)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Clomipramine (tricyclic antidepressant)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Disopyramide (antiarrhythmic)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (antipsychotic)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Sotalol (beta blocker)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Itraconazole (antifungal)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine (decongestant/anorectic)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Fenfluramine (appetite suppressant)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Midodrine (antihypotensive)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Digoxin (cardiac glycoside/antiarrhythmic)
Number of subjects: 59467

Group type: EXPERIMENTAL
Intervention: Procainamide (antiarrhythmic)
Number of subjects: 59467
Study: 21135270

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) delivered to 30 Gy in 15 fractions
Number of subjects: 340

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 340
Study: 18356180

Group type: EXPERIMENTAL
Intervention: Shockwave therapy
Number of subjects: 14
Study: 16735587

Group type: EXPERIMENTAL
Intervention: Scapular retraction position
Number of subjects: 30

Group type: COMPARATOR
Intervention: Empty-can arm position
Number of subjects: 30
Study: 14551341

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 5187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5187
Study: 11373850

Group type: EXPERIMENTAL
Intervention: Sonographic screening in the United Kingdom
Number of subjects: 65390

Group type: EXPERIMENTAL
Intervention: Sonographic screening in Western Australia
Number of subjects: 65390

Group type: EXPERIMENTAL
Intervention: Sonographic screening in Denmark
Number of subjects: 65390
Study: 9504729

Group type: EXPERIMENTAL
Intervention: Quinapril 20 mg once daily
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 96
Study: 8040678

Group type: EXPERIMENTAL
Intervention: Epirubicin and dexrazoxane (600/120 mg/m2, 900/120 mg/m2, 900/135 mg/m2, 900/150 mg/m2, 1,200/135 mg/m2)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Epirubicin alone
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Epirubicin and dexrazoxane
Number of subjects: 38
Study: 2493868

Group type: EXPERIMENTAL
Intervention: Counselling by health visitors (8 weekly visits)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no counselling)
Number of subjects: 60
Study: 9890791

Group type: EXPERIMENTAL
Intervention: Dipropylacetate (Depakine, 20 mg/kg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Phenobarbital (5 mg/kg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Primidone (25 mg/kg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 47
Study: 31088417

Group type: EXPERIMENTAL
Intervention: Intervention group (41 clubs)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (38 clubs)
Number of subjects: 79
Study: 28193663

Group type: EXPERIMENTAL
Intervention: Patient-targeted education about the etiology of URTIs, the role of antibiotics, and consequences of inappropriate antibiotic use.
Number of subjects: 914

Group type: COMPARATOR
Intervention: Control arm education on influenza vaccinations.
Number of subjects: 914
Study: 26444473

Group type: EXPERIMENTAL
Intervention: Personalized Diabetes Risk Score (DRS) provided at baseline, 12, and 24 weeks
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group received DRS at 12 and 24 weeks
Number of subjects: 192
Study: 23504552

Group type: EXPERIMENTAL
Intervention: Locomotor training program (LTP) - 36 therapist-provided sessions of walking training on a treadmill using body-weight support and practice overground at clinics
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Home exercise program (HEP) - 36 therapist-provided sessions of impairment-based strength and balance exercise at home
Number of subjects: 408

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 408
Study: 21554109

Group type: EXPERIMENTAL
Intervention: Yoga group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Educational film (control) group
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study: 19055279

Group type: EXPERIMENTAL
Intervention: Mimetic muscle acupuncture group (n = 79)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Routine acupoint group (n = 55)
Number of subjects: 134
Study: 16685332

Group type: EXPERIMENTAL
Intervention: Manual review using simple search and replace algorithms and visual scanning
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Automated review for easy PHI
Number of subjects: 262

Group type: COMPARATOR
Intervention: Comparison between manual and automated techniques
Number of subjects: 262
Study: 12665164

Group type: EXPERIMENTAL
Intervention: Experimental diet containing eicosapentaenoic acid, gamma-linolenic acid, and elevated antioxidants
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 98
Study: 11052845

Group type: EXPERIMENTAL
Intervention: Laser guidewire
Number of subjects: 303

Group type: COMPARATOR
Intervention: Mechanical guidewire
Number of subjects: 303
Study: 9175371

Group type: EXPERIMENTAL
Intervention: Topical antibiotic combined with piroxicam eye drops
Number of subjects: 75

Group type: COMPARATOR
Intervention: Topical antibiotic eye drops alone
Number of subjects: 75
Study: 1283661

Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA) 5 g administered after induction of anesthesia and 2 g/h during surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Aprotinin (APROT) 2.10(6) UIK administered after induction of anesthesia and 5.10(5) UIK/h during surgery
Number of subjects: 60
Study: 30700474

Group type: EXPERIMENTAL
Intervention: Perioperative CapeOX chemotherapy (up to four cycles every 3 weeks) plus radical surgery plus up to four cycles of postoperative chemotherapy
Number of subjects: 1370

Group type: COMPARATOR
Intervention: Postoperative chemotherapy (up to eight cycles after radical surgery)
Number of subjects: 1370
Study: 29301586

Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention (booklet and video, home visit at 34-36 weeks, telephone call 4 weeks after birth)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention
Number of subjects: 128

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 128
Study: 27062400

Group type: EXPERIMENTAL
Intervention: Family Based Treatment (FBT)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Systemic Family Therapy (SyFT)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 158
Study: 24641767

Group type: EXPERIMENTAL
Intervention: Tailored interventions to help implement NICE guidelines for overweight and obesity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 22955513

Group type: EXPERIMENTAL
Intervention: Moderate fat ingestion (MF) - 0.7 g of fat/kg body weight
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low fat ingestion (LF) - 0.4 g of fat/kg body weight
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Moderate fat ingestion (MF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low fat ingestion (LF)
Number of subjects: 20
Study: 19596616

Group type: EXPERIMENTAL
Intervention: Hydro-jet
Number of subjects: 79

Group type: COMPARATOR
Intervention: Needle injection
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 79
Study: 17914085

Group type: EXPERIMENTAL
Intervention: Subcutaneous granisetron (3 mg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Intravenous granisetron (3 mg)
Number of subjects: 31
Study: 16208801

Group type: EXPERIMENTAL
Intervention: Oscillating/pulsating power toothbrush (Oral‐B ProfessionalCare 7000; PC 7000)
Number of subjects: 35

Group type: COMPARATOR
Intervention: High-frequency power toothbrush (Philips Sonicare Elite; SE)
Number of subjects: 35
Study: 12362747

Group type: EXPERIMENTAL
Intervention: External ankle support (semi-rigid orthosis, air-cast, or high top shoes)
Number of subjects: 3954

Group type: COMPARATOR
Intervention: No external ankle support (control group)
Number of subjects: 3954
Study: 10419244

Group type: EXPERIMENTAL
Intervention: Parvovirus B19 infection
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Immunoglobulin treatment
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: High-dose steroids treatment
Number of subjects: 47
Study: 7484314

Group type: EXPERIMENTAL
Intervention: Substance Abuse Subtle Screening Inventory (SASSI)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Michigan Alcoholism Screening Test (MAST)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Five direct screening questions
Number of subjects: 495
Study: 2202231

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 7040496

Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 42

Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 42
Study: 30223911

Group type: EXPERIMENTAL
Intervention: ADT+brexpiprazole 1-3 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: ADT+placebo
Number of subjects: 0
Study: 27837671

Group type: EXPERIMENTAL
Intervention: d-cycloserine (125mg)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 26458986

Group type: EXPERIMENTAL
Intervention: Movi-Kids intervention (three hour-long sessions of recreational non-competitive physical activity after school, weekly; educational materials for parents and teachers; playground modifications)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 21
Study: 24081433

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES) 130/0.42
Number of subjects: 798

Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: Any bleeding
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: Severe bleeding
Number of subjects: 798
Study: 21819824

Group type: EXPERIMENTAL
Intervention: Closer monitoring by Westat staff
Number of subjects: 2168

Group type: COMPARATOR
Intervention: Standard monitoring by the Motor Vehicle Administration (Control)
Number of subjects: 2168
Study: 18584189

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A 1 unit
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 17223425

Group type: EXPERIMENTAL
Intervention: Lateral LV lead placement
Number of subjects: 61

Group type: COMPARATOR
Intervention: Posterolateral LV lead placement
Number of subjects: 61

Group type: COMPARATOR
Intervention: Anterior LV lead placement
Number of subjects: 61
Study: 15467498

Group type: EXPERIMENTAL
Intervention: Sufentanil (0.15 microg kg(‐1))
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tramadol (100 mg)
Number of subjects: 60
Study: 11583878

Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization
Number of subjects: 182

Group type: COMPARATOR
Intervention: Constant medical therapy
Number of subjects: 182
Study: 9337003

Group type: EXPERIMENTAL
Intervention: pyrimethamine and berberine
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: pyrimethamine and tetracycline
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: pyrimethamine and cotrimoxazole
Number of subjects: 215
Study: 7534847

Group type: EXPERIMENTAL
Intervention: Preventive therapy with pantripin and contrykal
Number of subjects: 587

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 587
Study: 3309812

Group type: EXPERIMENTAL
Intervention: Pefloxacin infusion for one hour
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Ofloxacin per os in one time
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Pefloxacin per os during 3 days
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (lens accumulation)
Number of subjects: 53
Study: 31754703

Group type: EXPERIMENTAL
Intervention: Darunavir/ritonavir (800/100 mg) + raltegravir (400 mg)
Number of subjects: 805

Group type: COMPARATOR
Intervention: Darunavir/ritonavir (800/100 mg) + tenofovir disoproxil fumarate/emtricitabine (245/200 mg once daily)
Number of subjects: 805
Study: 30421079

Group type: EXPERIMENTAL
Intervention: Robotic enucleation (EN Group)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Robotic demolitive resection (DR Group)
Number of subjects: 25
Study: 27914870

Group type: EXPERIMENTAL
Intervention: Agitation alone (Agi)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Aggression alone
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Rejection of care alone
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Agitation and aggression (Agi+Aggr)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Agitation and rejection (Agi+Rej)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Aggression and rejection
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: All three behaviors (Agi, Aggr, Rej)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Cognitive impairment
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Caregiver frustration
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Greater cognitive impairment
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Greater caregiver frustration
Number of subjects: 272